The historical rank and industry rank for Linical Co's Days Payable or its related term are showing as below:
During the past 13 years, Linical Co's highest Days Payable was 20.94. The lowest was 20.94. And the median was 20.94.
TSE:2183's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.76 * Ranked among companies with meaningful Days Payable only.
Linical Co's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
Linical Co Days Payable Related Terms
Linical Co Days Payable Historical Data
* Premium members only.
The historical data trend for Linical Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2183 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Linical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Linical Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Linical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Linical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Linical Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Linical Co (TSE:2183) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Linical Co and its competitors. Over the past decade, Linical Co's Days Payable has ranged from 20.94 to 20.94. According to the industry distribution chart, Linical Co ranks #999999 out of 703 companies in the Biotechnology industry.
Is Linical Co's Days Payable too high?
Linical Co's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 20.94 to a high of 20.94. Based on the distribution chart, Linical Co ranks #999999 out of 703 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Linical Co has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Linical Co ranks #999999 out of 703 companies for Days Payable. This places Linical Co in the lower half of its industry. The industry median Days Payable is 113.76. Historically, Linical Co's own Days Payable has ranged from 20.94 to 20.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Linical Co and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Linical Co's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円312.75, compared to a current price of 円205.00 — trading 34.5% below its estimated fair value. The current Days Payable is 0.00. Linical Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Linical Co (TSE:2183) Overvalued in 2026?
Based on GuruFocus' analysis, Linical Co stock appears to be undervalued.
The current stock price of 円205.00 is trading 34.5% below its estimated GF Value™ of 円312.75.
GuruFocus considers Linical Co to be Possible Value Trap.
Key valuation signals for TSE:2183:
Days Payable: 0.00
GF Value™: 円312.75 vs. price of 円205.00 (34.5% below fair value)
No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2183 has been successfully added to your 
